M National regulatory authority participation agreement and undertaking for national regulatory focal point(s), Appendix 1, Part A PDF Template
M Nitrosamine Contamination Policy for Finished Pharmaceutical Producs (FPPs) applications PDF Guideline/guidance
M Note with respect to WHO PQT/MED Recommended Product Information additional to the SRA Approved Product Information for Products Prequalified via the Abridged (SRA) Route PDF Guideline/guidance